Joined April 2025
23 Photos and videos
Couldn't catch every #irAE session at #ASCO26? We've got you! 🧡 Join @ASPIRE_CoP, @FunchainMD, @mhadfield30, @LZubiriOteiza & Dr. Pabani for ASPIRE's post-ASCO webinar 📅 June 17, 4 PM EST Free to join 👉shorturl.at/B2zt2 #immunotherapy
1
2
4
718
If you are a resident or fellow (in any specialty) please consider taking this survey to help ASPIRE develop #irAE and IOTOX education resources for medical trainees @FunchainMD @ASridharMD @DrKarineTawagi @mhadfield30 @OncBrothers @OncoAlert
📢 Residents & Fellows: Help shape the future of immunotherapy education! Participate in our 5-min anonymous survey on #irAE experiences.🩺 Program directors and faculty—please share with your trainees! Complete the survey:🔗 shorturl.at/GMNMY #ASPIRECOP #OncMedEd
4
525
ASPIRE Community of Practice retweeted
🚨irAE aficianados! Help shape @ASCO guidelines in part 1 of open comment on the next iteration of ASCO's irAE guidelines. Open for comment until Wed 6/10 ✍️ Part 1: 🫁👁️👄 Link to comment here 👇 asco1.qualtrics.com/jfe/form…
1
6
19
863
Live at #ASCO26: "Advancing ICI Therapy in High-Risk Populations" — rechallenge, transplant & combo toxicity. 📍E450a 🕖 4:45 - 6:00 PM CDT Takeaway: @MattCarlino  #immunotherapy #irAE
1
1
2
469
🔥 Exciting sessions to watch out for at #ASCO26! 🛡️ High-risk patients deserve immunotherapy too. How do we get them there safely? 📋 Advancing ICI Therapy in High-Risk Populations 🗓️ Mon Jun 1 🕖4:45–6:00 PM CT 📍 Room E450a #irAEs #immunotherapy
1
70
Big morning for #irAE research at #ASCO26 📍Hall A is full of it! A few we're watching: ICI rechallenge after irAE (#11127), CAR-T thyroid toxicity  (#11148), and pan-cancer genomic drivers of irAEs (#11132). Go see them!
3
5
181
A question for the #ASCO26 community: biggest unmet gap in managing checkpoint inhibitor pneumonitis? #irAE
0% Earlier recognition
100% Steroid-sparing options
0% Rechallenge decisions
0% Multidisciplinary care
1 votes • Final results
3
4
234
🔥 Exciting sessions to watch out for at #ASCO26! ⚔️ Bispecifics are powerful — and so are their toxicities. Grab the management playbook. 📋 Management of Bispecific Antibody Toxicities 🗓️ Sun May 31 🕞 11:30 AM–12:45 PM CT 📍 Room E450a #irAEs
59
🫁 Severe checkpoint inhibitor pneumonitis on steroids alone? Fresh phase 2 data on add-on ruxolitinib. 🎙️ Dr. Yan Xu · Peking Union Medical College Hospital 🗓️ Sun May 31 · 9:06 AM CT 📍 Room S403 #ASCO26 #irAEs #LungCancer
2
1
134
ASPIRE Community of Practice retweeted
Cannot be more excited for the @ASPIRE_CoP Mentoring Academy and our very first class of irAE fellows, led by Noha Abdel Wahab @CleClinicMD #ASCO26 @afreenshariffmd @KMittalmd
6
13
745
ASPIRE Community of Practice retweeted
Using all our resources for irAE: @afreenshariffmd identifies areas that AI can accelerate care for irAEs with agentic PRO and follow up @ASPIRE_CoP #ASCO26
7
5
409
ASPIRE Community of Practice retweeted
irAE strategy at @BrownMedicine led by @mhadfield30 starts with clinical need, which led to a multidisciplinary tumor board and a concerted effort of subspecialists to move sample collection forward @ASPIRE_CoP @afreenshariffmd @KMittalmd #ASCO26
4
3
301
ASPIRE Community of Practice retweeted
irAE strong 💪 Co chairs of @ASPIRE_CoP @KMittalmd and @afreenshariffmd review the growth of this international irAE consortium from humble beginnings in 2023-2024 @ProjDataSphere @ClevelandClinic many more. Now 1 year of @ASPIRE_CoP with 243 members 📈
1
3
9
342
ASPIRE Community of Practice retweeted
Building an IOTOX service line @kreynoldsMD @ASPIRE_CoP #ASCO26 ➡️align with institutional priorities ➡️name your program ➡️meet regularly and invite broadly ➡️connect to the scientific community ➡️start somewhere, a pilot project etc ➡️partner with patients @afreenshariffmd
1
4
9
229
ASPIRE Community of Practice retweeted
irAE aficionados! In 15 mins at S501abc, come to @ASPIRE_CoP to solve problems, improve QOL, get patients to life saving immunotherapy. Come get this beauty of a badge ribbon ✨ @afreenshariffmd @KMittalmd @kreynoldsMD @lexmeara @thenasheffect @EladSharonMD
4
12
326
Happening now: the ASPIRE Community of Practice is underway in S501abc! 🤝 #ASCO26 #irAE
1
48
Starting in 1 hour: ASPIRE Community of Practice, 4:30 PM, S501abc. If you manage immune-related adverse events, this is your room. 🧡 #ASCO26 #irAE
2
64
Happening now at #ASCO26: "From Novel Agents to Novel Adverse Events" — toxicity profiles of emerging therapies, covering the patient perspective, eye toxicities & cutaneous toxicities. S403, 8 AM. 👀 #irAE #immunotherapy
1
47
ASPIRE Community of Practice retweeted
Yes! 🙌 CoP time is the best time! @PallOncCoP #ASCO26
3
7
143
ASPIRE Community of Practice retweeted
Your handy guide to irAE and immune toxicity sessions at #ASCO26 @ASPIRE_CoP 🤓
5
11
392